Advertisement
Screener

EXICURE, INC. (XCUR) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

EXICURE, INC. Increase (Decrease) in Accrued Liabilities

EXICURE, INC. (XCUR) reported Increase (Decrease) in Accrued Liabilities of -$419.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14

  • EXICURE, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$19.00K.
  • EXICURE, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$400.00K, a 226.58% decline year-over-year.
  • EXICURE, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$22.00K.
  • EXICURE, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$698.00K, a 146.88% decline year-over-year.
  • EXICURE, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$614.00K, a 152.03% decline from fiscal 2024.
  • EXICURE, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $1.18M.
  • EXICURE, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$399.00K.
  • EXICURE, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$5.19M, a 284.49% decline from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accrued Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities 12 month as first filed
2026-06-30-$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$419.00K
10-Q · filed 2026-08-14
-$441.00K
derived: sum of 3 quarters · filed 2026-08-14
-$1.14M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$400.00K
10-Q · filed 2026-05-29
-$422.00K
derived: sum of 2 quarters · filed 2026-05-29
-$1.12M
derived: sum of 3 quarters · filed 2026-05-29
-$1.33M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$720.00K
derived: sum of 2 quarters · filed 2026-03-25
-$930.00K
derived: sum of 3 quarters · filed 2026-08-14
-$614.00K
10-K · filed 2026-03-25
2025-09-30-$698.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$908.00K
derived: sum of 2 quarters · filed 2026-08-14
-$592.00K
10-Q · filed 2025-11-07
-$869.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$210.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$106.00K
10-Q · filed 2026-08-14
-$171.00K
derived: sum of 3 quarters · filed 2026-08-14
$1.32M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$316.00K
10-Q · filed 2026-05-29
$39.00K
derived: sum of 2 quarters · filed 2026-05-29
$1.53M
derived: sum of 3 quarters · filed 2026-05-29
$1.54M
derived: sum of 4 quarters · filed 2026-05-29
2024-12-31-$277.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.21M
derived: sum of 2 quarters · filed 2026-03-25
$1.22M
derived: sum of 3 quarters · filed 2026-03-25
$1.18M
10-K · filed 2026-03-25
2024-09-30$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$1.50M
derived: sum of 2 quarters · filed 2025-11-07
$1.46M
10-Q · filed 2025-11-07
$980.00K
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$11.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$32.00K
10-Q · filed 2025-08-08
-$509.00K
derived: sum of 3 quarters · filed 2025-08-08
-$241.00K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31-$43.00K
10-Q · filed 2025-06-27
-$520.00K
derived: sum of 2 quarters · filed 2025-06-27
-$252.00K
derived: sum of 3 quarters · filed 2025-06-27
-$641.00K
derived: sum of 4 quarters · filed 2025-06-27
2023-12-31-$477.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$209.00K
derived: sum of 2 quarters · filed 2025-03-18
-$598.00K
derived: sum of 3 quarters · filed 2025-03-18
-$399.00K
10-K · filed 2025-03-18
2023-09-30$268.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$121.00K
derived: sum of 2 quarters · filed 2024-11-14
$78.00K
10-Q · filed 2024-11-14
-$1.66M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$389.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$190.00K
10-Q · filed 2024-08-13
-$1.93M
derived: sum of 3 quarters · filed 2024-08-13
-$2.22M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$199.00K
10-Q · filed 2024-06-17
-$1.54M
derived: sum of 2 quarters · filed 2024-06-17
-$1.83M
derived: sum of 3 quarters · filed 2024-06-17
-$1.75M
derived: sum of 4 quarters · filed 2024-06-17
2022-12-31-$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06
-$2.03M
derived: sum of 2 quarters · filed 2024-06-06
-$1.95M
derived: sum of 3 quarters · filed 2024-06-06
-$5.19M
10-K · filed 2024-06-06
2022-09-30-$292.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16
-$211.00K
derived: sum of 2 quarters · filed 2024-06-06
-$3.45M
10-Q · filed 2024-05-16
-$2.33M
derived: sum of 4 quarters · filed 2024-06-06
2022-06-30$81.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06
-$3.16M
10-Q/A · filed 2024-06-06
-$2.04M
derived: sum of 3 quarters · filed 2024-06-06
-$65.00K
derived: sum of 4 quarters · filed 2024-06-06
2022-03-31-$3.24M
10-Q/A · filed 2024-06-06
-$2.12M
derived: sum of 2 quarters · filed 2024-06-06
-$146.00K
derived: sum of 3 quarters · filed 2024-06-06
$658.00K
derived: sum of 4 quarters · filed 2024-06-06
2021-12-31$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
$3.09M
derived: sum of 2 quarters · filed 2023-03-27
$3.90M
derived: sum of 3 quarters · filed 2023-03-27
$2.81M
10-K · filed 2023-03-27
2021-09-30$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$2.78M
derived: sum of 2 quarters · filed 2022-11-14
$1.70M
10-Q · filed 2022-11-14
$3.33M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$804.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$280.00K
10-Q · filed 2022-08-15
$1.35M
derived: sum of 3 quarters · filed 2022-08-15
$1.54M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$1.08M
10-Q · filed 2022-05-16
$551.00K
derived: sum of 2 quarters · filed 2022-05-16
$737.00K
derived: sum of 3 quarters · filed 2022-05-16
$1.20M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$1.82M
derived: sum of 2 quarters · filed 2022-03-25
$2.28M
derived: sum of 3 quarters · filed 2022-03-25
$1.17M
10-K · filed 2022-03-25
2020-09-30$186.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19
$647.00K
derived: sum of 2 quarters · filed 2021-11-19
-$461.00K
10-Q · filed 2021-11-19
-$59.00K
derived: sum of 4 quarters · filed 2021-11-19
2020-06-30$461.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$647.00K
10-Q · filed 2021-08-12
-$245.00K
derived: sum of 3 quarters · filed 2021-08-12
-$3.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$1.11M
10-Q · filed 2021-05-12
-$706.00K
derived: sum of 2 quarters · filed 2021-05-12
-$464.00K
derived: sum of 3 quarters · filed 2021-05-12
-$478.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$402.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$644.00K
derived: sum of 2 quarters · filed 2021-03-11
$630.00K
derived: sum of 3 quarters · filed 2021-03-11
$578.00K
10-K · filed 2021-03-11
2019-09-30$242.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$228.00K
derived: sum of 2 quarters · filed 2020-11-12
$176.00K
10-Q · filed 2020-11-12
-$1.16M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$66.00K
10-Q · filed 2020-08-12
-$1.40M
derived: sum of 3 quarters · filed 2020-08-12
-$170.00K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31-$52.00K
10-Q · filed 2020-05-14
-$1.38M
derived: sum of 2 quarters · filed 2020-05-14
-$156.00K
derived: sum of 3 quarters · filed 2020-05-14
$226.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$104.00K
derived: sum of 2 quarters · filed 2020-03-10
$278.00K
derived: sum of 3 quarters · filed 2020-03-10
$270.00K
10-K · filed 2020-03-10
2018-09-30$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$1.61M
derived: sum of 2 quarters · filed 2019-11-07
$1.60M
10-Q · filed 2019-11-07
$1.91M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$382.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$374.00K
10-Q · filed 2019-08-08
$677.00K
derived: sum of 3 quarters · filed 2019-09-23
$973.00K
derived: sum of 4 quarters · filed 2019-09-23
2018-03-31-$8.00K
10-Q · filed 2019-05-08
$295.00K
derived: sum of 2 quarters · filed 2019-09-23
$591.00K
derived: sum of 3 quarters · filed 2019-09-23
$667.00K
derived: sum of 4 quarters · filed 2019-09-23
2017-12-31$303.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23
$599.00K
derived: sum of 2 quarters · filed 2019-09-23
$675.00K
derived: sum of 3 quarters · filed 2019-09-23
-$906.00K
10-K/A · filed 2019-09-23
-$811.00K
10-K · filed 2018-03-09
2017-09-30$296.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$372.00K
derived: sum of 2 quarters · filed 2018-11-06
-$1.21M
10-Q · filed 2018-11-06
-$948.00K
10-Q · filed 2017-11-14
$337.00K
derived: sum of 4 quarters · filed 2018-11-06
2017-06-30$76.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$1.50M
10-Q · filed 2018-08-06
$41.00K
derived: sum of 3 quarters · filed 2018-08-06
2017-03-31-$1.58M
10-Q · filed 2018-05-15
-$35.00K
derived: sum of 2 quarters · filed 2018-05-15
2016-12-31$1.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$1.55M
10-K · filed 2018-03-09
2016-09-30$2.00K
10-Q · filed 2017-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27